Alisa Opar is a California-based science writer and the articles editor at Audubon magazine.
Alisa Opar
Freelance writer
Simons Foundation
From this contributor
In search of truce in the autism wars
The fight between those who define autism as a medical condition and those who see it as a mere difference has reached vitriolic levels. Can the two sides come together to support all autistic people?
New group faces backlash over its goals for severe autism
A new advocacy group for people with severe autism taps into the deep divide in the community over who should speak for those on the spectrum.
New group faces backlash over its goals for severe autism
By
Alisa Opar
4 February 2019 | 6 min read
How to help low-income children with autism
Autistic children from low-income families are undercounted and underserved, a gap community leaders are working to bridge.
The healthcare system is failing autistic adults
Adults on the spectrum frequently have a range of other conditions — but they rarely get the help they need.
Why children with ‘severe autism’ are overlooked by science
Children with ‘severe autism’ are the most in need of help, yet the most overlooked in research. A new initiative is making them the primary focus.
Why children with ‘severe autism’ are overlooked by science
By
Alisa Opar
18 October 2017 | 21 min read
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
By
Lauren Schneider
4 February 2026 | 7 min read
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
By
Claudia López Lloreda
3 February 2026 | 4 min read
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
By
Calli McMurray
3 February 2026 | 6 min read